Viewing Study NCT04003792


Ignite Creation Date: 2025-12-24 @ 3:31 PM
Ignite Modification Date: 2025-12-27 @ 6:59 AM
Study NCT ID: NCT04003792
Status: UNKNOWN
Last Update Posted: 2020-10-20
First Post: 2019-06-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Treatment With Hepatic Arterial Infusion of Oxaliplatin in Combination With Systemic FOLFIRI Chemotherapy and Bevacuzimab in Patients With Liver-only Colorectal Liver Metastases (CRLM): Conversion to Complete Resection in Patients With Initially Inoperable Liver-only CRLM.
Sponsor: Rabin Medical Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module